CVS Group plc
CVS Group plc, together with its subsidiaries, engages in veterinary, online pharmacy, and retail businesses in the United Kingdom and Australia. It operates through the Veterinary Practices, Laboratories, and Online Retail Business segments. The company is involved in animal veterinary practices and complementary veterinary diagnostic businesses. It also operates Animed Direct, an online retail … Read more
CVS Group plc (CVSGF) - Total Liabilities
Latest total liabilities as of December 2024: $434.80 Million USD
Based on the latest financial reports, CVS Group plc (CVSGF) has total liabilities worth $434.80 Million USD as of December 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CVS Group plc - Total Liabilities Trend (2007–2024)
This chart illustrates how CVS Group plc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CVS Group plc Competitors by Total Liabilities
The table below lists competitors of CVS Group plc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Mabwell (Shanghai) Bioscience Co. Ltd. A
SHG:688062
|
China | CN¥3.58 Billion |
|
Hanma Technology Group Co Ltd
SHG:600375
|
China | CN¥4.94 Billion |
|
Enliven Therapeutics Inc.
NASDAQ:ELVN
|
USA | $16.68 Million |
|
Upbound Group Inc.
NASDAQ:UPBD
|
USA | $2.52 Billion |
|
Karoon Energy Ltd
PINK:KRNGY
|
USA | $741.10 Million |
|
MLS Co Ltd
SHE:002745
|
China | CN¥11.18 Billion |
|
Fastighets AB Balder Series B
LSE:0H2Z
|
UK | Skr146.66 Billion |
|
Vienna Insurance Group AG
PINK:VNRGF
|
USA | $45.46 Billion |
Liability Composition Analysis (2007–2024)
This chart breaks down CVS Group plc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.62 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CVS Group plc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CVS Group plc (2007–2024)
The table below shows the annual total liabilities of CVS Group plc from 2007 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-06-30 | $429.50 Million | +36.22% |
| 2023-06-30 | $315.30 Million | +4.82% |
| 2022-06-30 | $300.80 Million | +2.52% |
| 2021-06-30 | $293.40 Million | -1.44% |
| 2020-06-30 | $297.70 Million | +38.92% |
| 2019-06-30 | $214.30 Million | +32.86% |
| 2018-06-30 | $161.30 Million | -7.67% |
| 2017-06-30 | $174.70 Million | +9.32% |
| 2016-06-30 | $159.80 Million | +81.80% |
| 2015-06-30 | $87.90 Million | +37.56% |
| 2014-06-30 | $63.90 Million | +2.08% |
| 2013-06-30 | $62.60 Million | +5.29% |
| 2012-06-30 | $59.46 Million | -2.58% |
| 2011-06-30 | $61.03 Million | -4.70% |
| 2010-06-30 | $64.04 Million | +7.46% |
| 2009-06-30 | $59.59 Million | +10.38% |
| 2008-06-30 | $53.99 Million | +35.66% |
| 2007-06-30 | $39.80 Million | -- |